Pharmacological targeting of the HIF hydroxylases – A new field in medicine development-Reference-Cited by-同舟云学术

Pharmacological targeting of the HIF hydroxylases – A new field in medicine development

Published:2016-02 Issue: Volume:47-48 Page:54-75
ISSN:0098-2997
Container-title:Molecular Aspects of Medicine
language:en
Short-container-title:Molecular Aspects of Medicine

Author:

Chan Mun Chiang,Holt-Martyn James P.,Schofield Christopher J.,Ratcliffe Peter J.

Funder

Wellcome Trust

Biotechnology and Biological Sciences Research Council

Cancer Research UK

British Heart Foundation

Ludwig Institute for Cancer Research

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,General Medicine,Biochemistry

Reference207 articles.

1. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling;Adam;Cancer Cell,2011

2. Role of the jelly-roll fold in substrate binding by 2-oxoglutarate oxygenases;Aik;Curr. Opin. Struct. Biol,2012

3. Structural basis for inhibition of the fat mass and obesity associated protein (FTO);Aik;J. Med. Chem,2013

4. Structure of human RNA N6-methyladenine demethylase ALKBH5 provides insights into its mechanisms of nucleic acid recognition and demethylation;Aik;Nucleic Acids Res,2014

5. Introduction to structural studies on 2-oxoglutarate-dependent oxygenases and related enzymes, 2-oxoglutarate-dependent oxygenases;Aik;R. Soc. Chem,2015

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bibliometric and visualization analyses of cancer-related fatigue research published worldwide from 2001 to 2023;Frontiers in Oncology;2024-04-30

2. Selective Hypoxia-Sensitive Oxomer Formation by FIH Prevents Binding of the NF-κB Inhibitor IκBβ to NF-κB Subunits;Molecular and Cellular Biology;2024-04-02

3. Biochemistry of the hypoxia-inducible factor hydroxylases;Current Opinion in Chemical Biology;2024-04

4. Metabolic priming by multiple enzyme systems supports glycolysis, HIF1α stabilisation, and human cancer cell survival in early hypoxia;The EMBO Journal;2024-03-14

5. Growing concerns about using hypoxia-inducible factor prolyl hydroxylase inhibitors for the treatment of renal anemia;Clinical Kidney Journal;2024-02-28